logo-loader
AIM:REDX

Redx Pharma PLC

Receive alerts
Market:
AIM
Price
18.00 GBX
Day Change
-4.00%
Market Cap:
£70.02 m
52 weeks high
37.90
52 weeks low
17.00

In brief

Redx Pharma PLC is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted medicines for the treatment of fibrotic disease, cancer and the emerging area of cancer-associated fibrosis.

 

Snapshot

  • Redx Pharma launches trial of 'first-in-class' Crohn's disease drug
  • Redx Pharma strikes balance between in-house programmes and partnerships
  • Redx Pharma achieves milestone with dosing of first participant in Phase 1 clinical trial for RXC008